Home › Funds › Amundi US › PCVX
Amundi US position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)10.00K sh
Reported value held$581.47K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 5.79K | $115.00K | New |
| Q2 2022 | 2.60K | $64.00K | New |
| Q3 2022 | 2.60K | $62.00K | Hold |
| Q2 2023 | 262.60K | $12.92M | New |
| Q3 2023 | 342.91K | $15.77M | Add |
| Q4 2023 | 329.79K | $20.02M | Reduce |
| Q1 2024 | 302.36K | $18.33M | Reduce |
| Q2 2024 | 442.31K | $33.73M | Add |
| Q3 2024 | 434.79K | $48.59M | Reduce |
| Q4 2024 | 406.93K | $32.99M | Reduce |
| Q1 2025 | 343.51K | $10.50M | Reduce |
| Q4 2025 | 5.09K | $234.85K | New |
| Q1 2026 | 12.96K | $752.99K | Add |
| Q2 2026 | 10.00K | $581.47K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026